Kautzky-Willer Alexandra, Harreiter Jürgen, Pacini Giovanni
Gender Medicine Unit (A.K.-W., J.H.), Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria; and Metabolic Unit (G.P.), Institute of Neuroscience, National Research Council, 35127 Padua, Italy.
Endocr Rev. 2016 Jun;37(3):278-316. doi: 10.1210/er.2015-1137. Epub 2016 May 9.
The steep rise of type 2 diabetes mellitus (T2DM) and associated complications go along with mounting evidence of clinically important sex and gender differences. T2DM is more frequently diagnosed at lower age and body mass index in men; however, the most prominent risk factor, which is obesity, is more common in women. Generally, large sex-ratio differences across countries are observed. Diversities in biology, culture, lifestyle, environment, and socioeconomic status impact differences between males and females in predisposition, development, and clinical presentation. Genetic effects and epigenetic mechanisms, nutritional factors and sedentary lifestyle affect risk and complications differently in both sexes. Furthermore, sex hormones have a great impact on energy metabolism, body composition, vascular function, and inflammatory responses. Thus, endocrine imbalances relate to unfavorable cardiometabolic traits, observable in women with androgen excess or men with hypogonadism. Both biological and psychosocial factors are responsible for sex and gender differences in diabetes risk and outcome. Overall, psychosocial stress appears to have greater impact on women rather than on men. In addition, women have greater increases of cardiovascular risk, myocardial infarction, and stroke mortality than men, compared with nondiabetic subjects. However, when dialysis therapy is initiated, mortality is comparable in both males and females. Diabetes appears to attenuate the protective effect of the female sex in the development of cardiac diseases and nephropathy. Endocrine and behavioral factors are involved in gender inequalities and affect the outcome. More research regarding sex-dimorphic pathophysiological mechanisms of T2DM and its complications could contribute to more personalized diabetes care in the future and would thus promote more awareness in terms of sex- and gender-specific risk factors.
2型糖尿病(T2DM)及其相关并发症的急剧增加,伴随着越来越多关于临床上重要的性别差异的证据。男性T2DM在较低年龄和体重指数时更常被诊断出来;然而,最主要的危险因素即肥胖,在女性中更为常见。一般来说,各国的性别比例差异很大。生物学、文化、生活方式、环境和社会经济地位的差异影响着男性和女性在易感性、发病和临床表现方面的差异。遗传效应和表观遗传机制、营养因素和久坐不动的生活方式对男女的风险和并发症的影响各不相同。此外,性激素对能量代谢、身体成分、血管功能和炎症反应有很大影响。因此,内分泌失衡与不良的心脏代谢特征有关,在雄激素过多的女性或性腺功能减退的男性中可以观察到。生物学和社会心理因素都导致了糖尿病风险和预后的性别差异。总体而言,社会心理压力对女性的影响似乎大于男性。此外,与非糖尿病患者相比,女性患心血管疾病、心肌梗死和中风死亡的风险增加幅度大于男性。然而,当开始透析治疗时,男性和女性的死亡率相当。糖尿病似乎削弱了女性性别在心脏病和肾病发生中的保护作用。内分泌和行为因素参与了性别不平等并影响预后。更多关于T2DM及其并发症的性别二态性病理生理机制的研究,可能有助于未来实现更个性化的糖尿病护理,从而提高对性别特异性危险因素的认识。